A large number of drugs will be included in the focus of monitoring

A large number of drugs will be included in the focus of monitoring1.
Focus on monitoring drugsJune 30, 2020, the First People's Hospital of Neijiang City issued the "Focus on monitoring and rational drug use of drugs catalog (chemical drugs and biological products)", the catalog and July 1, 2019 issued by the National Health and Care Commission Medical And Political Hospital "on the issuance of the first batch of state key monitoring of rational drug catalog (chemical drugs and biological products) notice."the notice directory of a total of 20 varieties of neurokineloinlipid, brain nucleotide, olaxitan, sodium phosphonic acid, calf serum deprotein, according to the catalog provisions of these varieties of Neijiang City First People's Hospital should be "included in the catalog of all drugs to carry out prescription audit and prescription review, strengthen the publication, feedback and utilization of prescription review results." According to the notification requirements for some pharmaceutical hospitals should "take ranking notification, time-limited rectification, the removal of the agency's drug supply catalogue and other measures to ensure rational drug use." "
in accordance with last year's State Health and Care Commission Medical Administration and Hospital Authority notification requirements, in addition to the state's key monitoring of rational drug catalog, there are provincial and hospital-level secondary focus monitoring of reasonable drug catalogAccording to the requirements of this two-level key monitoring of reasonable drug catalog needs to be based on the national directory, the formulation of provincial and hospital-level directory, after the formulation should be reported to the National Health And Health Administration and the State Administration of Traditional Chinese Medicine for the record, and must be open to government affairs, open hospital affairs, official website publicity and other forms of public release to the communityThe base plate of the provincial and hospital-level secondary key monitoring of the catalogue of reasonable drugs should be a national catalogue, on the basis of the national directory, according to the actual number of varieties operated increase or decrease, in principle only increase or decreasethe current state key monitoring of rational drug catalog, has been implemented in various places, clearly made it clear that priority will be given to the national key monitoring varieties out of the catalog, such as Hubei Province, Zhejiang Province, Jiangsu Province, Fujian Province, Shanghai, Sichuan Province, Shaanxi Province, Gansu Province, Yunnan Province, Chongqing City, Guizhou, Shandong Province, Inner Mongolia, Guangdong Province, Jiangxi and other documents have been published2.
Which drugs, will be included in the key monitoringas the notice said, in addition to the national key monitoring of rational drug catalog, provinces and medical institutions can also be issued provincial and the agency focused on monitoring the catalog of reasonable drugs, then in this drug three-level monitoring directory of provincial and hospital-level have introduced what key monitoring of reasonable drug catalog?First: Provincial Key Monitoring Rational Drug Use Drug CatalogOctober 9, 2019, Zhejiang Provincial Health And Health Commission Office released the "First batch of Zhejiang Province focused on monitoring reasonable drug use catalog, provincial directory a total of 32 varieties, including 20 state-level monitoring drugs, as well as injection of thymus new, Kang ai injection, anti-cancer flat injection (intravenous injection), ginseng positive injection, cytophoin sodium, and other provincial key monitoring of the drugIn addition to Zhejiang Province, hainan, Jiangxi, Hubei, Guangxi, Shanxi, Anhui, Ningxia, etchave published provincial-level key monitoring of rational drug use catalogue (schedule)(Note: The author according to the local health and sanitation committee documents statistics) through the above eight provincial key monitoring reasonable drug catalog comparison can be seen, a total of 58 varieties involved in provincial key monitoring varieties, overlapping monitoring of varieties lansola, radorazole, danred injection, placenta peptides Injection, dredging injection five varieties, at most only three provinces overlap, due to Gansu Province, Heilongjiang, Jilin Province, Tibet Autonomous Region, Jiangsu Province, Fujian Province, Shanghai, Sichuan Province, Shaanxi Province, Yunnan Province, Chongqing City, Guizhou, Shandong, Inner Mongolia, Guangdong Province are the implementation of the national directory, no new provincial directory From 8 provincial data alone, provincial supplementary varieties due to local drug use differences in the habit, in the first batch of key monitoring varieties, the provincial does not have a unified regularity But there is a rule that can be seen that injections account for the majority of the proportion the second: hospital-level key monitoring of rational drug catalog July 26, 2019, Jiangxi Provincial People's Hospital issued "Jiangxi Provincial People's Hospital key monitoring of rational drug catalog" in addition to the country's 20 varieties, provincial 15 varieties, the hospital also developed a hospital focus on monitoring reasonable drug catalog, a total of atovastatin, clopidogre, Dizosin, butyl benzene, moxissac, cephalosporine shubatan, iodine-salin, tacros, mushroom polysaccharides, ginkgo diazepam glutamine, cephalosporine, merobinan, Conlet, nitrosped, acapo sugar and other 15 hospital-level varieties Of the 15 hospital-level varieties, oral drugs account for the majority of the proportion, and more characteristic are acapo sugar, atovastatin and other band-purchased varieties in addition to Jiangxi Provincial People's Hospital, the second affiliated hospital of Jiangxi University of Traditional Chinese Medicine has added 10 new hospital-level varieties, including blood plug-in, magpie equality varieties hospital-level key monitoring varieties are characterized by Jinggangshan University Hospital, the new dizosin injection, injection with thrombosis, mixed sugar electrolyte injection, injection with cephalosporine sodium saubatan sodium, injection with meroperinan, lotus biji injection, ginseng positive injection and other 15 hospital-level varieties are all injections in addition to general hospitals, specialized hospitals in the key monitoring varieties also have certain characteristics, such as Nanchang University affiliated oral hospital and Jiangxi Province Cancer Hospital, due to the special nature of the hospital department, oral hospital only left oxyfluoroxacin, 2 provincial varieties of radora In addition to national and provincial levels, the oncology hospital has added three unique hospital-level varieties, sodium sulphate, Ondansjun, polyethyl glycolreadiaresiserereres through the above-mentioned national, provincial, medical institutions three-level key monitoring of rational drug catalog can be seen, the top down in the variety structure has undergone some changes 1, from auxiliary drug to targeted drug transfer state-level 20 catalogs of nervous system drug use 10, cardiovascular 5, blood and hematopoietic drug 1, immunomodulator 3, bone and muscle medication 1, most of which are auxiliary drugs the provincial (Jiangxi Province) 15 catalogs of anti-infection 9, blood and hematopoietic drugs 1, anti-tumor 1, cardiovascular 3, digestive system 2 medical grade catalog further refined to the hospital department habitual drug catalog, with obvious department drug habits, such as Jiangxi Province Cancer Hospital for chemotherapy leading to vomiting 5-serotonin (5-HT3) receptor antagonist OndanSe, such as non-bone marrow cancer patients in the treatment of clinically significant fever neutrophils anti-cancer disease when the bone marrow inhibition of anti-cancer recombination human cell sulphate 2, gradually increase the focus of monitoring drugs
focus on monitoring drugs at the national level of 20, to the provincial level of 35, to Jiangxi Provincial People's Hospital 50, Jiangxi Province Cancer Hospital 38, Jiangxi University of Traditional Chinese Medicine Second Affiliated Hospital 45, Jinggangshan University Affiliated Hospital 50, in addition to a few specialties such as Nanchang University affiliated oral hospital, the rest of the hospital-level varieties are in the original national, provincial-level basis The same Hainan Province, Zhejiang Province, etc have this law 3, the future injection or key monitoring from the provincial, hospital-level key monitoring drug catalog, injections in some provinces as the key monitoring drug catalog accounted for a relatively large, such as Hainan Province added 10 provincial key monitoring drug catalog, of which injectionaccounted for 9 For example, Zhejiang Province added 12 provincial key monitoring drug catalogues, of which injections accounted for 8 in the hospital-level focus on monitoring the drug catalog, whether it is Jinggangshan University affiliated hospital is all injections, or Jiangxi University of Traditional Chinese Medicine Second Affiliated Hospital, etc , in the catalog has a certain amount of injection monitoring catalog 4, medical insurance limited Chinese medicine injections priority into the in the 2019 version of the medical insurance drug catalog, the basic use of chinese medicine injections for some of the basic requirements, restricting the use of the basic use of 26 to 33 kinds of injections from the 17th edition, only the second-level or above medical institutions can use, and made severe, disease and other restrictions through the above-mentioned provincial and hospital-level varieties can be seen, in the new version of the medical insurance drug catalog to limit the use of 33 kinds of injections at the grass-roots level, by the hospital-level monitoring of the hi-inflammatory injection, Danhong injection, wake-up quiet injection, Danhong injection and so on through the national, provincial and hospital-level monitoring drug catalog can be seen, nervous system treatment drugs, cardiovascular treatment drugs, tumor-assisted treatment, immunomodulation, antibacterial drugs, injections and other six major areas of drug use in the future key monitoring drugs catalog or will further narrow, no direct targeted treatment of drugs will be eliminated in the new batch of key monitoring drugs catalog currently state-level auxiliary drug use to the provincial regional drug use to the hospital department characteristic drug three-level key monitoring drug catalog standards, in this three-level drug catalog embarrassing enterprises may be further "embarrassing."